Amgen Joins Direct-To-Patient Rush With Repatha Program

 
• By Alaric DeArment
  
Amgen is offering direct sales of Repatha. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Market Access

More from Scrip